<DOC>
	<DOC>NCT01221987</DOC>
	<brief_summary>The current study will elucidate the human papillomavirus type distribution in a population of women diagnosed with cervical high grade pre-cancerous lesions and invasive cervical cancer in Sri Lanka.</brief_summary>
	<brief_title>Cross-sectional Study on Human Papillomavirus Type Distribution in Adult Women Diagnosed With Cervical Cancer</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<mesh_term>Uterine Neoplasms</mesh_term>
	<criteria>A female &gt; 21 years of age at the time of diagnosis of invasive cervical cancer or cervical intraepithelial neoplasia moderate or severe. Histologically confirmed diagnosis of cervix intraepithelial neoplasia moderate or severe, invasive cervical cancer, glandular lesions and other epithelial tumours. Written informed consent obtained from the subject prior to study start. Subjects who the investigator believes can and will comply with the requirements of the protocol, should be enrolled in the study. Previous vaccination against human papillomavirus. History of chemotherapy or radiotherapy for cervical cancer. Subjects with recurrent episodes of invasive cervical cancer or cervical intraepithelial neoplasia moderate or severe.</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Human papillomavirus</keyword>
	<keyword>neoplasia</keyword>
</DOC>